Charpentier tam sim no nyob hauv Lub Tebchaws Yelemees, qhov chaw nws yog tus thawj coj ntawm Txoj Cai Tswj Xyuas Kab Mob Biology ntawm Helmholtz Center for Infection Research thiab xibfwb ntawm Hannover Medical School. Nws kuj tseem koom nrog Lub Tsev Haujlwm Saib Xyuas Kev Tiv Thaiv Kab Mob Molecular ntawm Umea University, Sweden.
Emmanuelle Charpentier Jennifer doudna ua haujlwm nyob qhov twg?
Hnub no, hauv nws lub chaw kuaj mob Berlin ua tus thawj coj ntawm the Max Planck Lub Tsev Haujlwm Saib Xyuas Kev Noj Qab Haus Huv Biology, Charpentier txuas ntxiv mus kawm cov kab mob CRISPR thiab ua haujlwm ntawm kev hloov kho cov noob ntxiv. technology uas tshwm sim los ntawm nws.
Lub tuam txhab twg Emmanuelle Charpentier ua haujlwm rau?
In 2013 Charpentier co-founded CRISPR Therapeutics, lub tuam txhab uas ua haujlwm CRISPR txheej txheem rau kev kho noob hauv tib neeg, nrog kev ua haujlwm hauv Cambridge, Massachusetts, thiab lub hauv paus hauv paus hauv Zug, Switzerland. Charpentier yog ib tug tswv cuab ntawm lub tuam txhab lub rooj sab laj scientific.
Jennifer Doudna thiab Emmanuelle Charpentier ua haujlwm nyob qhov twg thiab lawv nto moo dab tsi?
University of California, Berkeley, biochemist Jennifer Doudna hnub no tau yeej 2020 Nobel nqi zog hauv Chemistry, sib koom nrog cov npoj yaig Emmanuelle Charpentier rau co-tsim ntawm CRISPR-Cas9, a genome kho kom ua tiav uas tau hloov kho biomedicine.
Puas yog Emmanuelle Charpentier ua haujlwm Jennifer doudna?
Lub 2020 Nobel nqi zog hauv Chemistry tau muab tsub koom ua ke rau European Academy ntawm Microbiology tus tswv cuab Emmanuelle Charpentier (Max Planck Unit rau Science of Pathogens, Berlin, Germany) thiab Jennifer A. Doudna (University of California, Berkeley, USA) rau " rau kev txhim kho ntawm txoj hauv kev rau kev kho genome ".
